|
|
Vol. 6.27 – 9 August, 2021
|
|
|
|
|
|
|
|
To explore the key extracellular matrix (ECM) proteins in the maintenance of the contractile phenotype of vascular smooth muscle cells (VSMCs), researchers applied protein-protein interaction network analysis to explore novel ECM proteins associated with the VSMC phenotype. [Circulation]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
|
|
Scientists generated sensorimotor organoids containing physiologically functional neuromuscular junctions and applied the model to different subgroups of amyotrophic lateral sclerosis. [Nature Communications]
|
|
|
|
|
|
The authors developed perturbation panel profiling as a framework for perturbing cells across many conditions and measuring gene expression responsiveness transcriptome-wide. [Cell Systems]
|
|
|
|
|
|
Investigators screened a library of 1280 bioactive compounds and identified those with potential cardiotoxic liabilities in induced pluripotent stem cell-cardiomyocytes using a single-parameter score based on deep learning.
[eLife]
|
|
|
|
|
|
Single-cell RNA sequencing was performed with human induced pluripotent stem cell-derived cardiomyocytes and endothelial cells in mono- and co-culture.
[Frontiers in Cell and Developmental Biology]
|
|
|
|
|
|
|
|
Researchers provided preclinical characterization of an antagomiR-218 molecule using the HSALR mouse model and patient-derived myotubes. [Molecular Therapy-Nucleic Acids]
|
|
|
|
|
|
Scientists generated human-induced pluripotent stem cells depleted in MBNL proteins and evaluated the consequences of their losses on the generation of skeletal muscle cells. [Human Molecular Genetics]
|
|
|
|
|
|
Using wild type, AUF1 knockout mice and cultured myoblasts, AUF1 supplementation of muscle fibers was found to increase expression of PGC1α, a major effector of skeletal muscle mitochondrial oxidative metabolism.
[Molecular Therapy-Methods & Clinical Development]
|
|
|
|
|
|
Comparing new-born with the other age groups, miR-10b, miR-126-5p, miR-143 and miR-146b were significantly up-regulated, whereas miR-21-5p, miR-221, miR-223 and miR-30b-5p were significantly down-regulated.
[Scientific Reports]
|
|
|
|
|
|
|
|
The authors harnessed CRISPR-Cas9 gene editing technology to introduce a mutation at cysteine 277 in the active site of the mouse Tgm2 gene. In vitro, a remodeling stimulus led to the significant loss of vascular compliance in wild-type mice, but not in the Tgm2-C277S or TG2−/− mice. [Cell Death Discovery]
|
|
|
|
|
|
Fluorescently labeled NLRP3 inflammasome particles were isolated from a mutant NLRP3-YFP cell line and used to treat primary human coronary artery smooth muscle cells for 4 and 24 hours.
[Scientific Reports]
|
|
|
|
|
|
Researchers studied the possible role and mechanism of AMOTL2 in regulating transforming growth factor-β1-induced proliferation and extracellular matrix deposition of airway smooth muscle cells. [Environmental Toxicology]
|
|
|
|
|
|
|
|
Myocardial ischemia or reperfusion increases the generation of reactive oxygen species from damaged mitochondria, NADPH oxidases, xanthine oxidase, and inflammation.
[Trends in Pharmacological Sciences]
|
|
|
|
|
|
The authors review the emerging contribution of fibro-adipogenic progenitors to skeletal muscle responses to motor neuron injuries and to systemic physiological or pathological metabolic perturbations.
[Seminars in Cell & Developmental Biology]
|
|
|
|
|
|
|
|
Avidity Biosciences, Inc. announced that the US FDA cleared the company to proceed with the Phase I/II MARINAâ„¢ clinical trial of AOC 1001 in adults with DM1. AOC 1001 is designed to address the root cause of DM1 by reducing levels of DMPK, the disease-related mRNA.
[Avidity Biosciences, Inc.]
|
|
|
|
|
|
PharmaTher Holdings Ltd. announced that the FDA has granted orphan drug designation for ketamine in the treatment of Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease.
[PharmaTher Holdings Ltd.]
|
|
|
|
|
|
|
|
November 29 – December 1, 2021
Barcelona, Spain
|
|
|
|
|
|
|
|
|
|
|
Buck Institute for Research on Aging – Novato, California, United States
|
|
|
|
|
|
|
Baylor College of Medicine – Houston, Texas, United States
|
|
|
|
|
|
|
Weill Cornell Medicine – New York, New York, United States
|
|
|
|
|
|
|
The Scripps Research Institute – La Jolla, California, United States
|
|
|
|
|
|
|
Pompeu Fabra University – Barcelona, Spain
|
|
|
|
|
|